Fractures that have failed to heal, joint cartilage problems, partial tears of tendons, muscles, or ligaments, chronic bursitis, avascular necrosis of the bone, and lumbar disc bulges.
Stem Cell Therapy With PRP and Tendon Injuries
Stem Cell Therapy/PRP is increasingly used in treatment of chronic non-healing tendon injuries including the elbow, patella, and the Achilles among others. As a result of mechanical factors, tendons are vulnerable to injury and stubborn to heal. Tendons also bear the responsibility of transferring a great deal of force, and as a result are susceptible to injury when they are overwhelmed. With repetitive overuse, collagen fibers in the tendon may form micro tears, leading to what is called tendonitis. The injured tendons heal by scarring which adversely affects function and increases risk of re-injury. Furthermore, tendons heal at a slow rate compared with other connective tissues, secondary to poor vascularization (blood supply).
Traditional therapies to treat these conditions do not alter the tendon’s inherent poor healing properties and involve long-term palliative care. Corticosteroids are commonly injected, however studies suggest adverse side effects including atrophy and permanent adverse structural changes in the tendon. Medications including NSAIDs, while commonly used for tendinopathies, carry significant long-term risks including bleeding ulcers and kidney damage. Thus, clinical use of Stem Cells treatments is growing.
Stem Cell Therapy with PRP and Elbow Injuries
A 2006 study in the American Journal of Sports Medicine, evaluated 140 patients with chronic epicondylar elbow pain. Of those patients, 20 were surgical candidates who had failed conservative treatments. The treatment group noted 60% improvement at 8 weeks, 81% at 6 months, and 93% at final follow-up at 12–38 months. Of note, there were no adverse effects or complications. Additionally, there was a 94% return to sporting activities and a 99% return to daily activities.
Stem Cell Therapy with PRP and Wounds
Non-healing wounds represent a challenging problem and are commonly related to peripheral vascular disease, infection, trauma, neurologic and immunologic conditions, as well as metabolic disorders.
A wound study published in the Journal of American Podiatry Medical Association 2006, involved 24 patients with 33 chronic non-healing lower extremity wounds. Patients failed conservative treatment for 6 months with a lack of reduction of surface area. The wounds were injected with PRP every 2 weeks. Successful wound closure was obtained in 20 wounds. Five wounds displayed no improvement. These findings were particularly significant because all patients had failed previously available treatment methods.